首页 > 最新文献

Journal of Ayurveda and Integrative Medicine最新文献

英文 中文
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-12-23 DOI: 10.1016/j.jaim.2025.101151
Bhushan Patwardhan
{"title":"","authors":"Bhushan Patwardhan","doi":"10.1016/j.jaim.2025.101151","DOIUrl":"10.1016/j.jaim.2025.101151","url":null,"abstract":"","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"17 1","pages":"Article 101151"},"PeriodicalIF":1.9,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145837390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral administration of osimertinib mesylate induced multiple peripheral neuropathy of a non-small-cell lung cancer patient and treated with traditional Chinese medicine - A case report 口服甲磺酸奥西替尼诱导非小细胞肺癌患者多发性周围神经病变1例并辅以中药治疗。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-12-22 DOI: 10.1016/j.jaim.2025.101225
Xiange Huang , Hegen Li , Ziming Li , Yilin Yao
Osimertinib mesylate (OM) is a third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) for the targeted treatment of non-small-cell lung cancer (NSCLC). To date, some adverse effects of OM (such as rhabdomyolysis, severe rash, etc.) have been reported in clinic, but no cases of OM-induced multiple peripheral neuropathy (MPN) have been documented. Here we report a rare case about oral administration of OM-induced MPN in a NSCLC patient and its treatment with traditional Chinese medicine (TCM) decoction. After taking OM orally to treat NSCLC for 2 months, a 70-year-old man experienced MPN symptoms including numbness in hand and foot, weakness in both lower limbs, limited mobility, and eventually the loss of the ability to stand and walk. Meanwhile, other known causes of MPN were ruled out. His symptoms did not improve after 24 days of discontinuing oral administration of OM. Subsequently, he received daily oral TCM decoction based on syndrome differentiation. One month later, his symptoms of MPN were relieved and the Total Neuropathy Score (TNS) was significantly reduced. He was able to stand and walk with the aid of a walker. The use of dialectical TCM decoction is a feasible treatment protocol to alleviate and even eliminate MPN symptoms. Further study is needed to investigate the mechanisms and preventive strategies of OM-induced MPN.
甲磺酸奥希替尼(OM)是第三代表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI),用于靶向治疗非小细胞肺癌(NSCLC)。迄今为止,临床已报道OM的一些不良反应(如横纹肌溶解、严重皮疹等),但未见OM引起的多发性周围神经病变(MPN)的病例。在此,我们报告一例罕见的口服om诱导的非小细胞肺癌患者的MPN并以中药汤剂治疗的病例。在口服OM治疗NSCLC 2个月后,一名70岁男性出现MPN症状,包括手脚麻木,双下肢无力,活动受限,最终丧失站立和行走能力。同时,其他已知的MPN原因也被排除。停用口服OM 24天后症状未见改善。随后每日口服中医辨证汤剂。1个月后,患者的MPN症状减轻,总神经病评分(TNS)明显降低。他在助行器的帮助下能够站立和行走。辨证中药汤剂是缓解甚至消除MPN症状的可行治疗方案。om诱导的MPN的机制和预防策略有待进一步研究。
{"title":"Oral administration of osimertinib mesylate induced multiple peripheral neuropathy of a non-small-cell lung cancer patient and treated with traditional Chinese medicine - A case report","authors":"Xiange Huang ,&nbsp;Hegen Li ,&nbsp;Ziming Li ,&nbsp;Yilin Yao","doi":"10.1016/j.jaim.2025.101225","DOIUrl":"10.1016/j.jaim.2025.101225","url":null,"abstract":"<div><div>Osimertinib mesylate (OM) is a third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) for the targeted treatment of non-small-cell lung cancer (NSCLC). To date, some adverse effects of OM (such as rhabdomyolysis, severe rash, etc.) have been reported in clinic, but no cases of OM-induced multiple peripheral neuropathy (MPN) have been documented. Here we report a rare case about oral administration of OM-induced MPN in a NSCLC patient and its treatment with traditional Chinese medicine (TCM) decoction. After taking OM orally to treat NSCLC for 2 months, a 70-year-old man experienced MPN symptoms including numbness in hand and foot, weakness in both lower limbs, limited mobility, and eventually the loss of the ability to stand and walk. Meanwhile, other known causes of MPN were ruled out. His symptoms did not improve after 24 days of discontinuing oral administration of OM. Subsequently, he received daily oral TCM decoction based on syndrome differentiation. One month later, his symptoms of MPN were relieved and the Total Neuropathy Score (TNS) was significantly reduced. He was able to stand and walk with the aid of a walker. The use of dialectical TCM decoction is a feasible treatment protocol to alleviate and even eliminate MPN symptoms. Further study is needed to investigate the mechanisms and preventive strategies of OM-induced MPN.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"17 1","pages":"Article 101225"},"PeriodicalIF":1.9,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145819304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of standalone personalized Ayurveda management in moderating functional index, inflammatory markers & radiological progression in Ankylosing Spondylitis with 12 years follow up – A case report 独立的个性化阿育吠陀治疗在缓解强直性脊柱炎功能指数、炎症标志物和影像学进展方面的疗效,随访12年- 1例报告
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-12-10 DOI: 10.1016/j.jaim.2025.101181
Somit Kumar , Kavitha Singh , Santhi Krishna A S
Ankylosing Spondylitis (AS) with extra-skeletal involvement predisposes patients to progressive axial spine complications affecting Quality of Life (QoL), if left untreated. A 21-year-old HLA B27 positive female affected with AS for twelve years, with multiple relapses and remissions had safety analysis of standalone Ayurvedic therapy during two pregnancies. Baseline and during disease flare-ups revealed elevated CRP levels. The current case reports the safety and efficacy of individualized Ayurveda interventions in ameliorating the progressive pathophysiology of AS with no clinical progression or radiological joint damage over time. The relative remission rate and progressive pathogenesis of AS can either be contained or arrested through Ayurveda, thereby improving the prognosis and QoL of an individual.
强直性脊柱炎(AS)伴有骨骼外受累,如果不及时治疗,患者易发生进行性轴向脊柱并发症,影响生活质量(QoL)。一名21岁的HLA B27阳性女性患AS 12年,多次复发和缓解,在两次怀孕期间进行了单独阿育吠陀治疗的安全性分析。基线和疾病发作期间显示CRP水平升高。目前的病例报告了个体化阿育吠陀干预在改善AS进行性病理生理方面的安全性和有效性,没有临床进展或放射关节损伤。通过阿育吠陀可以控制或阻止AS的相对缓解率和进行性发病机制,从而改善个体的预后和生活质量。
{"title":"Efficacy of standalone personalized Ayurveda management in moderating functional index, inflammatory markers & radiological progression in Ankylosing Spondylitis with 12 years follow up – A case report","authors":"Somit Kumar ,&nbsp;Kavitha Singh ,&nbsp;Santhi Krishna A S","doi":"10.1016/j.jaim.2025.101181","DOIUrl":"10.1016/j.jaim.2025.101181","url":null,"abstract":"<div><div>Ankylosing Spondylitis (AS) with extra-skeletal involvement predisposes patients to progressive axial spine complications affecting Quality of Life (QoL), if left untreated. A 21-year-old HLA B27 positive female affected with AS for twelve years, with multiple relapses and remissions had safety analysis of standalone Ayurvedic therapy during two pregnancies. Baseline and during disease flare-ups revealed elevated CRP levels. The current case reports the safety and efficacy of individualized Ayurveda interventions in ameliorating the progressive pathophysiology of AS with no clinical progression or radiological joint damage over time<strong>.</strong> The relative remission rate and progressive pathogenesis of AS can either be contained or arrested through Ayurveda, thereby improving the prognosis and QoL of an individual.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"17 1","pages":"Article 101181"},"PeriodicalIF":1.9,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145734478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prakriti and genetic profiling in Duchenne/Becker muscular dystrophy: An Ayurgenomic appraisal towards personalized care Duchenne/Becker肌营养不良症的Prakriti和基因分析:对个性化护理的Ayurgenomic评估
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-29 DOI: 10.1016/j.jaim.2025.101241
Pooja Trivedi , Dhruv Prajapati , Krishnakumari Patel , Khushi Dhamecha , Gaurang Sindhav

Background

Duchenne Muscular Dystrophy (DMD; OMIM #310200) and Becker Muscular Dystrophy (BMD; OMIM #300376) are rare and severe genetic conditions. These X-linked recessive Muscular Dystrophies (MDs) stem from variants in the DMD gene (OMIM #300377), encoding the dystrophin protein (Uniprot #P11532). The Prakriti concept, adjudged in Ayurveda, epitomizes an individual's nature-nurture and has gained significance in healthcare with the emerging field of Ayurgenomics.

Objective

The present research thoroughly analyses demographic, clinical, genetic, and Prakriti profiles in the D/BMD patients of Gujarat, India by integrating ancient wisdom with modern paradigms.

Materials and methods

This observational study included 120 male participants whose demographic and clinical data were assessed. The concentration of total CPK was measured. Genetic analysis methods, viz. MPCR, MLPA, and NGS were applied to identify variants. Prakriti profiles of all participants were assessed using AyuSoft.

Results

The demographic and clinical aspects of the study highlight the heterogeneity in disease severity and progression, with 15.83% of familial cases. The difference in CPK levels between DMD (12,445.15 U/L) and BMD (8,095 U/L) underscores the usual gradient in severity seen in these two types. Comprehensive genetic analysis revealed 87.5% DMD and 12.5% BMD, where 90% were identified as deletions, 4.17% duplications, and 5.83% point variants. In the cohort, 84.96% of variants were out-of-frame and 15.04% in-frame. Variant events were predominantly in distal regions (78.33%) and involved the central hotspot domain (65.83%). Among the detected deletions, 45-52 deletions exhibited dominantly in DMD participants with heightened frequency for exon 50. The study uniquely integrates Ayurvedic Prakriti profiles into the analysis, contributing additional insight into the disease framework. Based on seven distinct Prakritis, three profiles emerged prominently within our study. These are Kaphapradhaana Pittaanubandhi (KP), Kaphapradhaana Vaataanubandhi (KV), and Vaatapradhaana Kaphaanubandhi (VK). The distribution of Prakriti differed between DMD and BMD participants. In both groups, 46.67% had KP Prakriti, whereas DMD had 40.95% KV and 12.38% VK. Conversely, 53.33% of BMD participants had KV Prakriti, and VK Prakriti was absent.

Conclusion

The varying distribution of profiles introduces possibilities for Prakriti-based stratification of D/BMD. The multiple Factor Analysis (MFA) highlights the importance of age and Severity in the analysis. Such integrative Ayurgenomics holds promise for a deeper comprehension of genetic conditions and for paving the way for the development of innovative, real-time, and personalized management.
杜氏肌营养不良症(DMD; OMIM #310200)和贝克肌营养不良症(BMD; OMIM #300376)是罕见和严重的遗传病。这些x连锁隐性肌营养不良症(MDs)源于编码肌营养不良蛋白(Uniprot #P11532)的DMD基因(omim# 300377)的变异。阿育吠陀的Prakriti概念概括了个体的先天-后天,随着阿育基因组学这一新兴领域的出现,它在医疗保健领域获得了重要意义。目的本研究通过将古代智慧与现代范式相结合,深入分析印度古吉拉特邦D/BMD患者的人口统计学、临床、遗传学和Prakriti特征。材料与方法本观察性研究纳入了120名男性参与者,对其人口学和临床资料进行了评估。测定总CPK的浓度。应用遗传分析方法,即MPCR、MLPA和NGS来鉴定变异。使用AyuSoft对所有参与者的Prakriti档案进行评估。结果该研究的人口学和临床方面突出了疾病严重程度和进展的异质性,家族病例占15.83%。DMD (12,445.15 U/L)和BMD (8,095 U/L)之间CPK水平的差异强调了这两种类型中常见的严重程度梯度。综合遗传分析显示DMD为87.5%,BMD为12.5%,其中90%为缺失,4.17%为重复,5.83%为点变异体。在队列中,84.96%的变异在帧外,15.04%在帧内。变异事件主要发生在远端区域(78.33%),发生在中心热点区(65.83%)。在检测到的缺失中,45-52缺失主要出现在DMD参与者中,外显子50的频率升高。该研究独特地将阿育吠陀Prakriti概况整合到分析中,为疾病框架提供了额外的见解。基于七种不同的Prakritis,我们的研究中突出了三种特征。它们是Kaphapradhaana Pittaanubandhi (KP), Kaphapradhaana Vaataanubandhi (KV)和Vaatapradhaana Kaphaanubandhi (VK)。Prakriti的分布在DMD和BMD参与者之间存在差异。在两组中,46.67%的人有KP Prakriti,而DMD有40.95%的KV和12.38%的VK。相反,53.33%的BMD参与者有KV Prakriti, VK Prakriti不存在。结论剖面图的不同分布为基于prakriti的D/BMD分层提供了可能性。多因素分析(MFA)强调了年龄和严重程度在分析中的重要性。这种整合的Ayurgenomics有望更深入地理解遗传条件,并为创新、实时和个性化管理的发展铺平道路。
{"title":"Prakriti and genetic profiling in Duchenne/Becker muscular dystrophy: An Ayurgenomic appraisal towards personalized care","authors":"Pooja Trivedi ,&nbsp;Dhruv Prajapati ,&nbsp;Krishnakumari Patel ,&nbsp;Khushi Dhamecha ,&nbsp;Gaurang Sindhav","doi":"10.1016/j.jaim.2025.101241","DOIUrl":"10.1016/j.jaim.2025.101241","url":null,"abstract":"<div><h3>Background</h3><div>Duchenne Muscular Dystrophy (DMD; OMIM #310200) and Becker Muscular Dystrophy (BMD; OMIM #300376) are rare and severe genetic conditions. These X-linked recessive Muscular Dystrophies (MDs) stem from variants in the DMD gene (OMIM #300377), encoding the dystrophin protein (Uniprot #P11532). The Prakriti concept, adjudged in Ayurveda, epitomizes an individual's nature-nurture and has gained significance in healthcare with the emerging field of Ayurgenomics.</div></div><div><h3>Objective</h3><div>The present research thoroughly analyses demographic, clinical, genetic, and Prakriti profiles in the D/BMD patients of Gujarat, India by integrating ancient wisdom with modern paradigms.</div></div><div><h3>Materials and methods</h3><div>This observational study included 120 male participants whose demographic and clinical data were assessed. The concentration of total CPK was measured. Genetic analysis methods, <em>viz.</em> MPCR, MLPA, and NGS were applied to identify variants. Prakriti profiles of all participants were assessed using AyuSoft.</div></div><div><h3>Results</h3><div>The demographic and clinical aspects of the study highlight the heterogeneity in disease severity and progression, with 15.83% of familial cases. The difference in CPK levels between DMD (12,445.15 U/L) and BMD (8,095 U/L) underscores the usual gradient in severity seen in these two types. Comprehensive genetic analysis revealed 87.5% DMD and 12.5% BMD, where 90% were identified as deletions, 4.17% duplications, and 5.83% point variants. In the cohort, 84.96% of variants were out-of-frame and 15.04% in-frame. Variant events were predominantly in distal regions (78.33%) and involved the central hotspot domain (65.83%). Among the detected deletions, 45-52 deletions exhibited dominantly in DMD participants with heightened frequency for exon 50. The study uniquely integrates Ayurvedic Prakriti profiles into the analysis, contributing additional insight into the disease framework. Based on seven distinct Prakritis, three profiles emerged prominently within our study. These are <em>Kaphapradhaana</em> <em>Pittaanubandhi</em> (KP), <em>Kaphapradhaana</em> <em>Vaataanubandhi</em> (KV), and <em>Vaatapradhaana</em> <em>Kaphaanubandhi</em> (VK). The distribution of Prakriti differed between DMD and BMD participants. In both groups, 46.67% had KP Prakriti, whereas DMD had 40.95% KV and 12.38% VK. Conversely, 53.33% of BMD participants had KV Prakriti, and VK Prakriti was absent.</div></div><div><h3>Conclusion</h3><div>The varying distribution of profiles introduces possibilities for Prakriti-based stratification of D/BMD. The multiple Factor Analysis (MFA) highlights the importance of age and Severity in the analysis. Such integrative Ayurgenomics holds promise for a deeper comprehension of genetic conditions and for paving the way for the development of innovative, real-time, and personalized management.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"17 1","pages":"Article 101241"},"PeriodicalIF":1.9,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immediate effect of Suryanamaskar on cardiorespiratory functions and cognitive performance: A quasi-experimental study on young adult females Suryanamaskar对年轻成年女性心肺功能和认知能力的直接影响:一项准实验研究
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101224
Anjali Singh , Sanjoy Majhi , Arnab Das

Background

Suryanamaskar (SN) is popular amongst recent yoga practitioners for its health benefits and fitness promises. Most previous studies have focused on the long-term pre-post effects of SN intervention on health and fitness. However, a notable gap exists regarding the immediate response of practicing SN on cardiorespiratory and neuro-cognitive functions, especially in the female population.

Objectives

This study aimed to find the immediate effect of SN practice on cardiorespiratory functions and neuro-cognitive performance in healthy adult females.

Material and methods

A total of 21 healthy females (aged: 18–25 years) were selected in this Quasi pre-post experimental study, guided by the CONSORT tool. Cardiorespiratory, heart rate (HR) variability, and cognitive parameters were assessed before and immediately after 45 minutes of SN session using a metabolic gas analyzer, HR sensor, and psychometric tests, respectively. Paired t-test was performed to find the difference between the pre- and post-SN responses.

Results

A significant increase in average volume of oxygen consumption (VO2) (11.4 %; p < 0.01), minute ventilation (VE) (15.9 %; p < 0.001), respiratory frequency (Rf) (6.2 %; p < 0.01), respiratory quotient (RQ) (4.6 %; p < 0.01), and METS (12.4 %; p < 0.001) were observed immediately after SN session. No significant changes in blood pressure was observed. LF power (23.7 %; p < 0.01) and LF/HF ratio (79.9 %; p < 0.05) showed a significant increase along with a decrease in pNN50 % (16.9 %; p < 0.05) and HF power (16.4 %; p < 0.01) at post-SN. A significant improvement (p < 0.01) in Stroop congruent (14.78 %) and incongruent (13.7 %) reaction times was also observed immediately after the SN session.

Conclusion

These findings collectively indicate that a single session of SN effectively enhanced both cardiorespiratory and cognitive functions, which can be used to improve cardiometabolic health and to train the autonomic nervous system in females.
suryanamaskar (SN)因其健康益处和健身承诺在最近的瑜伽练习者中很受欢迎。以往的研究大多集中在SN干预对健康和健身的长期前后影响上。然而,关于SN练习对心肺和神经认知功能的即时反应,特别是在女性人群中,存在明显的差距。目的探讨瑜伽练习对健康成年女性心肺功能和神经认知功能的直接影响。材料与方法采用CONSORT工具进行准实验前后研究,选取年龄在18-25岁的健康女性21例。分别使用代谢气体分析仪、心率传感器和心理测量测试评估心肺、心率(HR)变异性和认知参数。配对t检验发现sn前后反应的差异。结果SN治疗后,平均耗氧量(VO2) (11.4%; p < 0.01)、分钟通气量(VE) (15.9%; p < 0.001)、呼吸频率(Rf) (6.2%; p < 0.01)、呼吸商(RQ) (4.6%; p < 0.01)和METS (12.4%; p < 0.001)均显著升高。血压未见明显变化。sn后低频段功率(23.7%;p < 0.01)和低频段/高频比(79.9%;p < 0.05)显著升高,pNN50 % (16.9%; p < 0.05)和高频功率(16.4%;p < 0.01)显著降低。在Stroop一致(14.78%)和不一致(13.7%)的反应时间上也有显著改善(p < 0.01)。结论单次SN可有效增强女性的心肺功能和认知功能,可用于改善女性心脏代谢健康和训练自主神经系统。
{"title":"Immediate effect of Suryanamaskar on cardiorespiratory functions and cognitive performance: A quasi-experimental study on young adult females","authors":"Anjali Singh ,&nbsp;Sanjoy Majhi ,&nbsp;Arnab Das","doi":"10.1016/j.jaim.2025.101224","DOIUrl":"10.1016/j.jaim.2025.101224","url":null,"abstract":"<div><h3>Background</h3><div>Suryanamaskar (SN) is popular amongst recent yoga practitioners for its health benefits and fitness promises. Most previous studies have focused on the long-term pre-post effects of SN intervention on health and fitness. However, a notable gap exists regarding the immediate response of practicing SN on cardiorespiratory and neuro-cognitive functions, especially in the female population.</div></div><div><h3>Objectives</h3><div>This study aimed to find the immediate effect of SN practice on cardiorespiratory functions and neuro-cognitive performance in healthy adult females.</div></div><div><h3>Material and methods</h3><div>A total of 21 healthy females (aged: 18–25 years) were selected in this Quasi pre-post experimental study, guided by the CONSORT tool. Cardiorespiratory, heart rate (HR) variability, and cognitive parameters were assessed before and immediately after 45 minutes of SN session using a metabolic gas analyzer, HR sensor, and psychometric tests, respectively. Paired <em>t</em>-test was performed to find the difference between the pre- and post-SN responses.</div></div><div><h3>Results</h3><div>A significant increase in average volume of oxygen consumption (VO<sub>2</sub>) (11.4 %; p &lt; 0.01), minute ventilation (VE) (15.9 %; p &lt; 0.001), respiratory frequency (Rf) (6.2 %; p &lt; 0.01), respiratory quotient (RQ) (4.6 %; p &lt; 0.01), and METS (12.4 %; p &lt; 0.001) were observed immediately after SN session. No significant changes in blood pressure was observed. LF power (23.7 %; p &lt; 0.01) and LF/HF ratio (79.9 %; p &lt; 0.05) showed a significant increase along with a decrease in pNN50 % (16.9 %; p &lt; 0.05) and HF power (16.4 %; p &lt; 0.01) at post-SN. A significant improvement (p &lt; 0.01) in Stroop congruent (14.78 %) and incongruent (13.7 %) reaction times was also observed immediately after the SN session.</div></div><div><h3>Conclusion</h3><div>These findings collectively indicate that a single session of SN effectively enhanced both cardiorespiratory and cognitive functions, which can be used to improve cardiometabolic health and to train the autonomic nervous system in females.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101224"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145417808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A randomised double blind placebo-controlled clinical trial to evaluate the effects of Liv-Pro- a food supplement for Non-Alcoholic Fatty Liver Disease 一项随机双盲安慰剂对照临床试验,评估非酒精性脂肪性肝病的食物补充剂Liv-Pro的效果。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101196
Anchala Ishani Kuruppu , Uditha Prabhath Liyanage , Aruni Chamika , Priyani Asoka Paranagama , Lankani Hettigoda

Background

Non-alcoholic Fatty Liver Disease (NAFLD) involves excessive fat build-up in the liver unrelated to alcohol use. This study aimed to evaluate the clinical efficacy and safety of Liv-Pro capsules, a formulation combining Osbeckia octandra and Aloe vera, in managing NAFLD. This is the first report of the clinical trial using this combination against NAFLD.

Methods

A randomized, double-blind, placebo-controlled clinical trial was conducted with 30 NAFLD patients from February 1, 2021 to March 31, 2023. Participants received either Liv-Pro or a placebo (two capsules once a day) for two months. Medical assessments at baseline, one month, and two months included liver function tests (ALT and AST), abdominal ultrasound scan, serum creatinine analysis, and lipid profile assessment. All patients were advised on lifestyle modifications.

Results

Liv-Pro significantly reduced ALT levels after one month (p = 0.049) and two months (p = 0.048) compared to baseline. AST levels also decreased significantly in the first (p = 0.047) and second months (p = 0.046), showing a consistent decline. Liv-Pro reduced total cholesterol, triglycerides, and Low-density lipoprotein (LDL) levels significantly after one and two months (p < 0.05) compared to baseline measurements. Abdominal ultrasound scans showed a significant decrease in hepatic fat content after two months (p = 0.020). Serum creatinine levels remained stable throughout the treatment period.

Conclusion

Liv-Pro was well-tolerated with no reported side effects, suggesting its potential as a safe and effective therapeutic option for NAFLD. Continuous administration of Liv-Pro is recommended for sustained efficacy.
背景:非酒精性脂肪性肝病(NAFLD)涉及与酒精使用无关的肝脏过度脂肪堆积。本研究旨在评价由八芒藤和芦荟联合制成的Liv-Pro胶囊治疗NAFLD的临床疗效和安全性。这是首个使用该联合疗法治疗NAFLD的临床试验报告。方法:于2021年2月1日至2023年3月31日对30例NAFLD患者进行随机、双盲、安慰剂对照临床试验。参与者要么服用live - pro,要么服用安慰剂(每天两次),持续两个月。基线、1个月和2个月的医学评估包括肝功能检查(ALT和AST)、腹部超声扫描、血清肌酐分析和血脂评估。建议所有患者改变生活方式。结果:与基线相比,live - pro在1个月(p = 0.049)和2个月(p = 0.048)后显著降低ALT水平。AST水平在第1个月(p = 0.047)和第2个月(p = 0.046)也显著下降,呈现一致性下降。在1个月和2个月后,Liv-Pro显著降低了总胆固醇、甘油三酯和低密度脂蛋白(LDL)水平(p)。结论:Liv-Pro耐受性良好,无副作用报道,表明它有可能成为一种安全有效的治疗NAFLD的选择。建议持续使用live - pro以保持疗效。
{"title":"A randomised double blind placebo-controlled clinical trial to evaluate the effects of Liv-Pro- a food supplement for Non-Alcoholic Fatty Liver Disease","authors":"Anchala Ishani Kuruppu ,&nbsp;Uditha Prabhath Liyanage ,&nbsp;Aruni Chamika ,&nbsp;Priyani Asoka Paranagama ,&nbsp;Lankani Hettigoda","doi":"10.1016/j.jaim.2025.101196","DOIUrl":"10.1016/j.jaim.2025.101196","url":null,"abstract":"<div><h3>Background</h3><div>Non-alcoholic Fatty Liver Disease (NAFLD) involves excessive fat build-up in the liver unrelated to alcohol use. This study aimed to evaluate the clinical efficacy and safety of Liv-Pro capsules, a formulation combining <em>Osbeckia octandra</em> and <em>Aloe vera</em>, in managing NAFLD. This is the first report of the clinical trial using this combination against NAFLD.</div></div><div><h3>Methods</h3><div>A randomized, double-blind, placebo-controlled clinical trial was conducted with 30 NAFLD patients from February 1, 2021 to March 31, 2023. Participants received either Liv-Pro or a placebo (two capsules once a day) for two months. Medical assessments at baseline, one month, and two months included liver function tests (ALT and AST), abdominal ultrasound scan, serum creatinine analysis, and lipid profile assessment. All patients were advised on lifestyle modifications.</div></div><div><h3>Results</h3><div>Liv-Pro significantly reduced ALT levels after one month (p = 0.049) and two months (p = 0.048) compared to baseline. AST levels also decreased significantly in the first (p = 0.047) and second months (p = 0.046), showing a consistent decline. Liv-Pro reduced total cholesterol, triglycerides, and Low-density lipoprotein (LDL) levels significantly after one and two months (p &lt; 0.05) compared to baseline measurements. Abdominal ultrasound scans showed a significant decrease in hepatic fat content after two months (p = 0.020). Serum creatinine levels remained stable throughout the treatment period.</div></div><div><h3>Conclusion</h3><div>Liv-Pro was well-tolerated with no reported side effects, suggesting its potential as a safe and effective therapeutic option for NAFLD. Continuous administration of Liv-Pro is recommended for sustained efficacy.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101196"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145504465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urine retention in elderly male due to hypo-contractile bladder treated successfully through Ayurveda – A Case Report 阿育吠陀成功治疗老年男性膀胱收缩不足所致尿潴留1例
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101258
Sanjeev Rastogi , Shashwat Rastogi
Urine retention is a common problem in elderly people. In male it is often associated with prostatic hypertrophy and can also be associated with hypo contractile bladder. Such functional disorders of bladder do not respond well to conventional medicine and the only respite is given by catheterization either in situ or intermittent as per the requirement. Besides social stigma, catheterization has its own accompanying problems leading to its poor acceptance. Newer approaches like electrical stimulation, Sacral neuro-modulation and stem cell therapy for this clinical condition are still in the process of development. Ayurveda earlier has reported to have successfully treated such cases to the extent of complete recovery. We present here a case of 83 year old male who was not able to pass the urine due to bladder hypo contractility and was on self-retaining catheter for about 2 years, got clinically cured with the help of Ayurveda interventions taken for about a year. A follow up of the case was done for another two years to find him well without any medication. This case endorses the worth of Ayurveda interventions in such cases and warrants a serious enquiry about such interventions to generate more robust evidences.
尿潴留是老年人的常见问题。在男性中,它通常与前列腺肥大有关,也可能与膀胱收缩不足有关。这种膀胱功能障碍对常规药物反应不佳,唯一的缓解方法是根据需要进行原位或间歇导尿。除了社会耻辱感之外,导尿术也有其自身的问题,导致其接受度较低。新的治疗方法如电刺激、骶骨神经调节和干细胞治疗仍在发展中。阿育吠陀早前曾报道成功治疗了这类病例,达到完全康复的程度。我们在此报告一例83岁的男性患者,由于膀胱收缩不足而无法排尿,在使用自留导尿管约2年后,在阿育吠陀治疗的帮助下,临床治愈了大约1年。对该病例进行了另外两年的随访,发现他没有任何药物治疗。这个案例支持阿育吠陀在这种情况下干预的价值,并保证对这种干预进行认真的调查,以产生更有力的证据。
{"title":"Urine retention in elderly male due to hypo-contractile bladder treated successfully through Ayurveda – A Case Report","authors":"Sanjeev Rastogi ,&nbsp;Shashwat Rastogi","doi":"10.1016/j.jaim.2025.101258","DOIUrl":"10.1016/j.jaim.2025.101258","url":null,"abstract":"<div><div>Urine retention is a common problem in elderly people. In male it is often associated with prostatic hypertrophy and can also be associated with hypo contractile bladder. Such functional disorders of bladder do not respond well to conventional medicine and the only respite is given by catheterization either in situ or intermittent as per the requirement. Besides social stigma, catheterization has its own accompanying problems leading to its poor acceptance. Newer approaches like electrical stimulation, Sacral neuro-modulation and stem cell therapy for this clinical condition are still in the process of development. Ayurveda earlier has reported to have successfully treated such cases to the extent of complete recovery. We present here a case of 83 year old male who was not able to pass the urine due to bladder hypo contractility and was on self-retaining catheter for about 2 years, got clinically cured with the help of Ayurveda interventions taken for about a year. A follow up of the case was done for another two years to find him well without any medication. This case endorses the worth of Ayurveda interventions in such cases and warrants a serious enquiry about such interventions to generate more robust evidences.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101258"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145463174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of yoga therapy as an add-on to conventional medicine in improving cognitive functions and depressive symptoms in major depressive disorder: A case report 瑜伽疗法作为常规药物的补充在改善重度抑郁症的认知功能和抑郁症状方面的效果:一个病例报告
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101219
Ekta Mishra, Shivam Sharma, Kashinath G. Metri
Major depressive disorder is a common mental disorder with a lifetime prevalence of 4.4 % worldwide. Cognitive dysfunction is a consequence of MDD. A 27-year-old female with MDD since 2015 experienced an acute MDD episode with anxiety, extreme sadness, poor memory, and impaired attention in July 2023 after discontinuation of anti-depressants. She was on anti-depressants since 2023, yet symptoms persisted. She enrolled in yoga therapy in January 2024. Yoga therapy consisted of a 60-min yoga session every day of the week for 12 weeks. She was followed up twice, on the 15th and 90th day. The selective and sustained attention, working memory and depressive symptoms were assessed using the Attention Network Test, Colour Stroop test, Corsi Block test, and the Beck Depression Inventory-II, respectively. There was marked improvement in selected and sustained attention and depressive symptoms but no improvement in working memory on the 90th day compared to baseline and 15th day. This case study concludes that yoga therapy as an add-on to the conventional treatment of MDD may enhance cognition and reduce depressive symptoms in patients with MDD who have a poor response to conventional anti-depressant treatment. This case study provides insights into the possible role of yoga in MDD patients who poorly respond to conventional anti-depressant therapy.
重度抑郁症是一种常见的精神障碍,全世界终生患病率为4.4%。认知功能障碍是重度抑郁症的一个后果。一名27岁女性自2015年以来患有重度抑郁症,在停用抗抑郁药后,于2023年7月出现急性重度抑郁症发作,伴有焦虑、极度悲伤、记忆力差和注意力受损。她从2023年开始服用抗抑郁药,但症状持续存在。她于2024年1月报名参加瑜伽治疗。瑜伽疗法包括每周每天60分钟的瑜伽练习,持续12周。在第15天和第90天对患者进行了两次随访。分别采用注意网络测试、Colour Stroop测试、Corsi Block测试和Beck抑郁量表ii评估选择性和持续注意、工作记忆和抑郁症状。与基线和第15天相比,第90天的选择性和持续性注意力和抑郁症状有显著改善,但工作记忆没有改善。本案例研究的结论是,瑜伽疗法作为MDD常规治疗的补充,可以提高认知能力,减轻对常规抗抑郁治疗反应不佳的MDD患者的抑郁症状。这个案例研究为瑜伽在对传统抗抑郁治疗反应不佳的重度抑郁症患者中可能发挥的作用提供了见解。
{"title":"Effect of yoga therapy as an add-on to conventional medicine in improving cognitive functions and depressive symptoms in major depressive disorder: A case report","authors":"Ekta Mishra,&nbsp;Shivam Sharma,&nbsp;Kashinath G. Metri","doi":"10.1016/j.jaim.2025.101219","DOIUrl":"10.1016/j.jaim.2025.101219","url":null,"abstract":"<div><div>Major depressive disorder is a common mental disorder with a lifetime prevalence of 4.4 % worldwide. Cognitive dysfunction is a consequence of MDD. A 27-year-old female with MDD since 2015 experienced an acute MDD episode with anxiety, extreme sadness, poor memory, and impaired attention in July 2023 after discontinuation of anti-depressants. She was on anti-depressants since 2023, yet symptoms persisted. She enrolled in yoga therapy in January 2024. Yoga therapy consisted of a 60-min yoga session every day of the week for 12 weeks. She was followed up twice, on the 15th and 90th day. The selective and sustained attention, working memory and depressive symptoms were assessed using the Attention Network Test, Colour Stroop test, Corsi Block test, and the Beck Depression Inventory-II, respectively. There was marked improvement in selected and sustained attention and depressive symptoms but no improvement in working memory on the 90th day compared to baseline and 15th day. This case study concludes that yoga therapy as an add-on to the conventional treatment of MDD may enhance cognition and reduce depressive symptoms in patients with MDD who have a poor response to conventional anti-depressant treatment. This case study provides insights into the possible role of yoga in MDD patients who poorly respond to conventional anti-depressant therapy.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101219"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145463175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Ayurveda and Sri Lankan traditional medicine in post hemorrhagic stroke rehabilitation - A Case Report 阿育吠陀与斯里兰卡传统医学在出血性中风后康复中的作用- 1例报告。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101222
A.M.H.S. Attanayake , U.M.G.D. De Silva , A. Upadhyay , A.K. Sahu , P.K. Perera
Stroke due to intracerebral hemorrhage is the most destructive subtype often causing disabilities in survivors. Early motor recovery, improving quality of life and improved social participation are the key aspects of stroke rehabilitation. Ayurveda describes stroke as Pakshaghata and categorized it as a Vata dominant disease.
This case reports the effect of Ayurveda and Sri Lankan traditional medicine in post stroke rehabilitation of a 60-year-old male, known case of diabetes and hypertension with recent left sided hemiplegia due to hemorrhage in the basal ganglia and hemorrhage in the lateral ventricle.
Following initial management at a modern facility for three weeks, the patient received Ayurveda and Sri Lankan traditional interventions for three months in addition to conventional treatment. Improvement was monitored using visual analogue scale, improvement in neurological and motor functions, clinical parameters, quality of life with stroke specific quality of life index, and life satisfaction questionnaire.
Significant improvement in motor functions, muscle tone, rigidity and hyperreflexia were observed. Patient's bladder-bowel control and functional abilities also improved leading to better quality of life. Better control of blood pressure and glucose levels was also observed indicating positive outcomes of integration of Ayurveda with conventional therapy in such cases. No adverse effects were observed during the observation period.
This case report suggests that Ayurveda and folklore medicine may play an important role in improving neuromuscular functions, quality of life and speedy rehabilitation of stroke patients.
脑出血引起的中风是最具破坏性的亚型,经常导致幸存者残疾。早期运动恢复,改善生活质量和改善社会参与是中风康复的关键方面。阿育吠陀将中风描述为Pakshaghata,并将其归类为Vata显性疾病。本病例报告了阿育吠陀和斯里兰卡传统医学对一名60岁男性中风后康复的影响,该患者已知患有糖尿病和高血压,近期因基底节区出血和侧脑室出血导致左侧偏瘫。在现代化设施进行了三周的初步管理后,除了常规治疗外,患者还接受了三个月的阿育吠陀和斯里兰卡传统干预。采用视觉模拟量表、神经和运动功能改善、临床参数、生活质量(卒中特定生活质量指数)和生活满意度问卷监测改善情况。观察到运动功能、肌肉张力、强直和高反射性明显改善。患者的膀胱-肠控制和功能能力也得到改善,从而提高了生活质量。在这种情况下,还观察到更好地控制血压和血糖水平,表明阿育吠陀与传统治疗相结合的积极结果。观察期间未见不良反应。本病例报告提示阿育吠陀和民间医学可能在改善脑卒中患者的神经肌肉功能、生活质量和快速康复方面发挥重要作用。
{"title":"Role of Ayurveda and Sri Lankan traditional medicine in post hemorrhagic stroke rehabilitation - A Case Report","authors":"A.M.H.S. Attanayake ,&nbsp;U.M.G.D. De Silva ,&nbsp;A. Upadhyay ,&nbsp;A.K. Sahu ,&nbsp;P.K. Perera","doi":"10.1016/j.jaim.2025.101222","DOIUrl":"10.1016/j.jaim.2025.101222","url":null,"abstract":"<div><div>Stroke due to intracerebral hemorrhage is the most destructive subtype often causing disabilities in survivors. Early motor recovery, improving quality of life and improved social participation are the key aspects of stroke rehabilitation. Ayurveda describes stroke as Pakshaghata and categorized it as a Vata dominant disease.</div><div>This case reports the effect of Ayurveda and Sri Lankan traditional medicine in post stroke rehabilitation of a 60-year-old male, known case of diabetes and hypertension with recent left sided hemiplegia due to hemorrhage in the basal ganglia and hemorrhage in the lateral ventricle.</div><div>Following initial management at a modern facility for three weeks, the patient received Ayurveda and Sri Lankan traditional interventions for three months in addition to conventional treatment. Improvement was monitored using visual analogue scale, improvement in neurological and motor functions, clinical parameters, quality of life with stroke specific quality of life index, and life satisfaction questionnaire.</div><div>Significant improvement in motor functions, muscle tone, rigidity and hyperreflexia were observed. Patient's bladder-bowel control and functional abilities also improved leading to better quality of life. Better control of blood pressure and glucose levels was also observed indicating positive outcomes of integration of Ayurveda with conventional therapy in such cases. No adverse effects were observed during the observation period.</div><div>This case report suggests that Ayurveda and folklore medicine may play an important role in improving neuromuscular functions, quality of life and speedy rehabilitation of stroke patients.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101222"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145451954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rediscovery of Vrikshayurveda: A nature-based vision for sustainability 重新发现维里克沙尤尔吠陀:基于自然的可持续性愿景。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101239
Rajesh Kotecha , Deep Narayan Pandey
The rediscovery of Vrikshayurveda principles offers a holistic framework to address contemporary environmental challenges and support sustainability goals. This analysis provides three foundational principles—Resource Utilization and Regeneration, No Harm to Nature, and Resource Conservation—rooted in the Atharva Veda and integrates ancient wisdom with modern ecological science. Through an exploration of Vedic texts and contemporary literature, these principles are shown to align with regenerative agriculture, natural forest regeneration, and biodiversity conservation, offering practical, scalable, and cost-effective solutions. Their applications extend to urban forestry, regenerative agriculture, and ecosystem recovery, demonstrating the potential to enhance soil health, improve carbon sequestration, and facilitate community-based conservation efforts. Furthermore, this approach also highlights how ancient practices, such as water harvesting and agroforestry, can inform modern strategies to achieve global restoration targets, environmental management, urban greening, and human health promotion. Future research should examine how Vrikshayurveda principles, in conjunction with contemporary science, can systematically be integrated into contemporary conservation policies, bridging cultural heritage with scientific advancements to create resilient ecosystems and sustainable societies through nature-based solutions.
Vrikshayurveda原则的重新发现为解决当代环境挑战和支持可持续发展目标提供了一个整体框架。这一分析以《阿闼婆吠陀》为基础,将古代智慧与现代生态科学相结合,提出了资源利用与再生、不损害自然、节约资源三大基本原则。通过对吠陀文本和当代文献的探索,这些原则与可再生农业、自然森林再生和生物多样性保护相一致,提供了实用、可扩展和具有成本效益的解决方案。它们的应用扩展到城市林业、再生农业和生态系统恢复,展示了增强土壤健康、改善碳固存和促进社区保护工作的潜力。此外,这种方法还强调了诸如集水和农林业等古老做法如何为实现全球恢复目标、环境管理、城市绿化和促进人类健康的现代战略提供信息。未来的研究应该研究如何将弗立克沙育吠陀原则与当代科学相结合,系统地融入当代保护政策,将文化遗产与科学进步联系起来,通过基于自然的解决方案创造有弹性的生态系统和可持续的社会。
{"title":"Rediscovery of Vrikshayurveda: A nature-based vision for sustainability","authors":"Rajesh Kotecha ,&nbsp;Deep Narayan Pandey","doi":"10.1016/j.jaim.2025.101239","DOIUrl":"10.1016/j.jaim.2025.101239","url":null,"abstract":"<div><div>The rediscovery of Vrikshayurveda principles offers a holistic framework to address contemporary environmental challenges and support sustainability goals. This analysis provides three foundational principles—Resource Utilization and Regeneration, No Harm to Nature, and Resource Conservation—rooted in the Atharva Veda and integrates ancient wisdom with modern ecological science. Through an exploration of Vedic texts and contemporary literature, these principles are shown to align with regenerative agriculture, natural forest regeneration, and biodiversity conservation, offering practical, scalable, and cost-effective solutions. Their applications extend to urban forestry, regenerative agriculture, and ecosystem recovery, demonstrating the potential to enhance soil health, improve carbon sequestration, and facilitate community-based conservation efforts. Furthermore, this approach also highlights how ancient practices, such as water harvesting and agroforestry, can inform modern strategies to achieve global restoration targets, environmental management, urban greening, and human health promotion. Future research should examine how Vrikshayurveda principles, in conjunction with contemporary science, can systematically be integrated into contemporary conservation policies, bridging cultural heritage with scientific advancements to create resilient ecosystems and sustainable societies through nature-based solutions.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101239"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145458720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ayurveda and Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1